- Blankfein says he'll be in office when not getting treatment
- CEO says better quarters ahead for him and the company
Goldman Sachs Group Inc. Chief Executive Officer Lloyd C. Blankfein, who announced last month that he has lymphoma, told employees he’ll still be bothering many of them as he undergoes chemotherapy, according to a person briefed on the remarks.
Blankfein, 61, told managing directors on a conference call Thursday that his treatments would follow a three-week cycle, with one week of treatment and two weeks off, said the person, who asked not to be identified because the conversation wasn’t public. The CEO dialed into that internal quarterly call to discuss third-quarter earnings, which fell 36 percent from a year earlier.
Blankfein said he will be in the office when he isn’t receiving treatment, the person said. He said last month that his lymphoma was “highly curable" and that he’ll be able to work “substantially as normal."
On Thursday’s call, Blankfein praised strong quarters from the firm’s investment-banking and investment-management divisions, the person said. Investment-banking revenue rose 6 percent from a year earlier, the only segment to post an increase.
While fixed-income trading fell more than rivals, Blankfein noted that there had been many past quarters where that division had carried the firm, the person said. Blankfein joked that both he and the company have better quarters ahead.